Zoll medical corporation evaluated the device and the device performed to specification.The device passed the final test and was recertified and returned to the customer.The ecg analysis of the recorded clinical file was reviewed.There were twelve analyses performed during the event, for one of which a shock was advised.The report reviewed the "shock advised".The first analysis in the case resulted in a shock advised.Of the three segments of the ecg analysis, segments 1 and 2 were determined to be shockable, presenting vtach greater than 150 bpm.The main contributing factors to this result were high recorded heart rates, low normalized amplitudes, high qrs variabilities, and high recorded percent width measurements in each segment.The remaining eleven analysis events all resulted in non-shockable determinations, and all contained clear asystolic rhythms and were correctly analyzed by the algorithm.It was determined that the aed plus device worked as designed and configured, and within the limitations of the technology available.Analysis of reports of this type has not identified an increase in trend.
|